<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diamond-Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo> (<z:chebi fb="28" ids="35299">DBA</z:chebi>) is a congenital <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndrome characterized by a specific deficiency in erythroid progenitors </plain></SENT>
<SENT sid="1" pm="."><plain>Since some patients with <z:chebi fb="28" ids="35299">DBA</z:chebi> develop a reduction in thrombocytes and granulocytes with age, we asked whether multipotent hematopoietic progenitors from <z:chebi fb="28" ids="35299">DBA</z:chebi> patients had <z:mpath ids='MPATH_458'>normal</z:mpath> proliferative capacity in liquid expansion cultures </plain></SENT>
<SENT sid="2" pm="."><plain>CD34(+) cells derived from <z:chebi fb="28" ids="35299">DBA</z:chebi> patients showed deficient proliferation in liquid culture containing IL-3, IL-6, and SCF </plain></SENT>
<SENT sid="3" pm="."><plain>Single CD34(+) CD38(-) cells from <z:chebi fb="28" ids="35299">DBA</z:chebi> patients exhibited deficient proliferation recruitment in a limiting dilution assay containing IL-3, IL-6, SCF, Tpo, FL, and G-CSF or containing IL-3, IL-6, and SCF </plain></SENT>
<SENT sid="4" pm="."><plain>Our findings suggest that the underlying hematopoietic defect in <z:chebi fb="28" ids="35299">DBA</z:chebi> may not be limited to the erythroid lineage </plain></SENT>
<SENT sid="5" pm="."><plain>Since a fraction of <z:chebi fb="28" ids="35299">DBA</z:chebi> patients have a deficiency in ribosomal protein S19 (RPS19), we constructed lentiviral vectors containing the RPS19 gene for overexpression in hematopoietic progenitors from RPS19-deficient <z:chebi fb="28" ids="35299">DBA</z:chebi> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Enforced expression of the RPS19 transgene improved the proliferation of CD34(+) cells from <z:chebi fb="28" ids="35299">DBA</z:chebi> patients with RPS19 mutation </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, enforced expression of RPS19 improved erythroid development of RPS19-deficient hematopoietic progenitors as determined by colony assays and erythroid differentiation cultures </plain></SENT>
<SENT sid="8" pm="."><plain>These findings suggest that gene therapy for RPS19-deficient <z:chebi fb="28" ids="35299">DBA</z:chebi> is feasible </plain></SENT>
</text></document>